Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Actuate Therapeutics Inc. Common stock
ACTU | US
2.97
USD0.44
17.39%
ACTU | US
Loading StockChartView...
About Actuate Therapeutics Inc. Common stock
Sector
8/13/2024
Industry
8/13/2024
Earnings date
30/06/2024
As of date
24/04/2026
Close
2.97
Open
2.54
High
3.09
Low
2.48
View Less
ACTU | US
Risk
172.1
Sharpe
-0.79
Luna's Score
43/100
Recommendation
Sell
Luna says (ACTU | US)
What's Working
Strength based on increasing price with high volume
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
187.5%1 month
172.1%3 months
125.2%6 months
100.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
62.55M
MarketCap(USD)
62.55M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-
Short ratio
0.06
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.52
Range1M
1.52
Range3M
4.18
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.42
Price X volume
841.40K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | - | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 125.18 | - | - |
| Debt to Equity | - | - | - |
| Debt to Assets | - | - | - |
| Market Cap | 62.55M | - | - |
